MINI FUTURE ZERTIFIKAT LONG - AMGEN | Real-time BOERSE MUENCHEN 01:05:30 25/06/2024 am IST | ||
| 1.25 EUR | +4.17% |
|
| Current month | +10.62% | ||
| 1 month | +8.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 1.25 | +4.17% |
| 21/24/21 | 1.2 | +0.84% |
| 20/24/20 | 1.19 | +2.59% |
| 19/24/19 | 1.16 | +0.87% |
| 18/24/18 | 1.15 | +1.77% |
Real-time BOERSE MUENCHEN
Last update June 25, 2024 at 01:05 am IST
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | TT0LLK |
| ISIN | DE000TT0LLK8 |
| Date issued | 28/01/2020 |
| Strike | 182.7 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.56 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.38 € |
|---|---|
| Lowest since issue | 0.17 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
318.2
USD
Average target price
316.4
USD
Spread / Average Target
-0.54%
- Stock Market
- Certificates
- Certificat
